Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain

The neuromuscular junction (NMJ) consists of a tripartite synapse with a presynaptic nerve terminal, Schwann cells that ensheathe the terminal bouton, and a highly specialized postsynaptic membrane. Synaptic structural integrity is crucial for efficient signal transmission. Congenital myasthenic syndromes (CMSs) are a heterogeneous group of inherited disorders that result from impaired neuromuscular transmission, caused by mutations in genes encoding proteins that are involved in synaptic transmission and in forming and maintaining the structural integrity of NMJs. To identify further causes of CMSs, we performed whole-exome sequencing (WES) in families without an identified mutation in known CMS-associated genes. In two families affected by a previously undefined CMS, we identified homozygous loss-of-function mutations in COL13A1, which encodes the alpha chain of an atypical non-fibrillar collagen with a single transmembrane domain. COL13A1 localized to the human muscle motor endplate. Using CRISPR-Cas9 genome editing, modeling of the COL13A1 c.1171delG (p.Leu392Sfs∗71) frameshift mutation in the C2C12 cell line reduced acetylcholine receptor (AChR) clustering during myotube differentiation. This highlights the crucial role of collagen XIII in the formation and maintenance of the NMJ. Our results therefore delineate a myasthenic disorder that is caused by loss-of-function mutations in COL13A1, encoding a protein involved in organization of the NMJ, and emphasize the importance of appropriate symptomatic treatment for these individuals.

• Publication year

  2015

• Venue

  American Journal of Human Genetics

• Publication date

  2015-11-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ajhg.2015.10.017PMID 26626625PMCID 4678414
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.

  2015cited by this paper
• Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.

  2015cited by this paper
• Inherited disorders of the neuromuscular junction: an update

  2014cited by this paper
• Congenital myasthenic syndromes: an update

  2013influential reference
• Multiplex Genome Engineering Using CRISPR/Cas Systems

  2013cited by this paper
• Genome engineering using the CRISPR-Cas9 system

  2013cited by this paper
• SAMS, a syndrome of short stature, auditory-canal atresia, mandibular hypoplasia, and skeletal abnormalities is a unique neurocristopathy caused by mutations in Goosecoid.

  2013cited by this paper
• From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline

  2013cited by this paper
• Congenital myasthenic syndromes.

  2013cited by this paper
• Synaptic basal lamina–associated congenital myasthenic syndromes

  2012influential reference
• A framework for variation discovery and genotyping using next-generation DNA sequencing data

  2011cited by this paper
• The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

  2010cited by this paper
• Muscle-Derived Collagen XIII Regulates Maturation of the Skeletal Neuromuscular Junction

  2010influential reference
• The Sequence Alignment/Map format and SAMtools

  2009cited by this paper
• The Role of Glial Cells in the Formation and Maintenance of the Neuromuscular Junction

  2008cited by this paper
• Distinct target-derived signals organize formation, maturation, and maintenance of motor nerve terminals.

  2007cited by this paper
• Congenital myasthenic syndromes

  2004cited by this paper
• The Type XIII Collagen Ectodomain Is a 150-nm Rod and Capable of Binding to Fibronectin, Nidogen-2, Perlecan, and Heparin*

  2002cited by this paper
• Lack of cytosolic and transmembrane domains of type XIII collagen results in progressive myopathy.

  2001cited by this paper
• Distinct recognition of collagen subtypes by alpha(1)beta(1) and alpha(2)beta(1) integrins. Alpha(1)beta(1) mediates cell adhesion to type XIII collagen.

  2000cited by this paper
• Type XIII Collagen Forms Homotrimers with Three Triple Helical Collagenous Domains and Its Association into Disulfide-bonded Trimers Is Enhanced by Prolyl 4-Hydroxylase*

  2000cited by this paper
• Distinct Recognition of Collagen Subtypes by α1β1 and α2β1Integrins

  2000cited by this paper
• Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme.

  1998cited by this paper
• The alpha 1 chain of type XIII collagen consists of three collagenous and four noncollagenous domains, and its primary transcript undergoes complex alternative splicing.

  1990cited by this paper
• Gene structure for the alpha 1 chain of a human short-chain collagen (type XIII) with alternatively spliced transcripts and translation termination codon at the 5' end of the last exon.

  1988cited by this paper
• Congenital Myasthenic Syndromes

  1985cited by this paper
• Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor

  year unknowncited by this paper

• New Insights into Neuromuscular Junction Biology: Evidence from Human and Animal Research

  2026cites this paper
• GFPT1-related congenital myasthenic syndrome misdiagnosed as myopathy: clinical and genetic insights

  2025cites this paper
• TRANSMEMBRANE AND MULTIPLEXIN COLLAGENS IN DEVELOPMENT AND PATHOBIOLOGY.

  2025cites this paper
• Salbutamol in Congenital Myasthenic Syndrome: A Systematic Review

  2025cites this paper
• A method for finding epistatic effects of maternal and fetal variants

  2025cites this paper
• Expression of Collagen XIII in Tissues of the Thyroid and Orbit With Relevance to Thyroid-Associated Ophthalmopathy

  2024cites this paper
• Collagen XIII Is the Key Molecule of Neurovascular Junctions in the Neuroendocrine System

  2024cites this paper
• The Caenorhabditis elegans cuticle and precuticle: a model for studying dynamic apical extracellular matrices in vivo

  2024cites this paper
• Unraveling ptosis: a comprehensive review of clinical manifestations, genetics, and treatment.

  2024cites this paper
• Rare disease research workflow using multilayer networks elucidates the molecular determinants of severity in Congenital Myasthenic Syndromes

  2023cites this paper
• Targeting neuromuscular junction to treat neuromuscular disorders.

  2023cites this paper
• Congenital Myasthenic Syndromes

  2023cites this paper
• Contribution of collagen XIII to lung function and development of pulmonary fibrosis

  2023cites this paper
• COL28 promotes proliferation, migration, and EMT of renal tubular epithelial cells

  2023cites this paper
• Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes—A Comprehensive Review

  2023cites this paper
• A ligand-receptor interactome atlas of the zebrafish

  2023cites this paper
• Congenital myasthenic syndromes (CMS) a rare cause of uncommon fatigue

  2022cites this paper
• Genome-wide expression screening in the cardiac embryonic stem cell test shows additional differentiation routes that are regulated by morpholines and piperidines

  2022cites this paper
• The CMS19 disease model specifies a pivotal role for collagen XIII in bone homeostasis

  2022cites this paper
• Moderate phenotype of a congenital myasthenic syndrome type 19 caused by mutation of the COL13A1 gene: a case report

  2022influential citation
• A local regulatory network in the testis mediated by laminin and collagen fragments that supports spermatogenesis

  2021cites this paper
• Collagens as New Players in Nervous System Diseases

  2021cites this paper
• Congenital myasthenic syndromes: where do we go from here?

  2021cites this paper
• Functions of the extracellular matrix in development: Lessons from Caenorhabditis elegans.

  2021cites this paper
• Transmembrane Collagens in Neuromuscular Development and Disorders

  2021influential citation
• [Advances in the diagnosis and treatment of congenital myasthenic syndrome].

  2020cites this paper
• Collagens at the vertebrate neuromuscular junction, from structure to pathologies.

  2020cites this paper
• Exploring the roles of MACIT and Multiplexin collagens in stem cells and cancer.

  2020cites this paper
• Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability

  2020cites this paper
• A Neonate With MuSK Congenital Myasthenic Syndrome Presenting With Refractory Respiratory Failure

  2020cites this paper
• Integrin α11β1 is a receptor for collagen XIII

  2020cites this paper
• The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and Homeostasis

  2020cites this paper
• Transmembrane collagens—Unexplored mediators of epidermal‐dermal communication and tissue homeostasis

  2020cites this paper
• Endplattenerkrankungen

  2020cites this paper
• The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations

  2019cites this paper
• Genetic Basis of Congenital Myasthenic Syndrome: A Review Study

  2019cites this paper
• Correct expression and localization of collagen XIII are crucial for the normal formation and function of the neuromuscular system

  2019cites this paper
• Congenital myasthenic syndrome caused by novel COL13A1 mutations

  2019cites this paper
• Collagen XIII and Other ECM Components in the Assembly and Disease of the Neuromuscular Junction

  2019influential citation
• Congenital myasthenic syndromes

  2019influential citation
• Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome

  2019cites this paper
• Congenital myasthenic syndrome type 19 due to a novel mutation in the COL13A1 GENE

  2019cites this paper
• Microhomologies are prevalent at Cas9-induced larger deletions

  2019cites this paper
• Collagen XIII-derived ectodomain regulates bone angiogenesis and intracortical remodeling.

  2019cites this paper
• Increasing phenotypic annotation improves the diagnostic rate of exome sequencing in a rare neuromuscular disorder

  2019cites this paper
• Skeletal muscle: A review of molecular structure and function, in health and disease

  2019cites this paper
• Trouble at the junction: When myopathy and myasthenia overlap

  2019cites this paper
• Collagens and elastin genetic variations and their potential role in aging-related diseases and longevity in humans.

  2019cites this paper
• The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations

  2019cites this paper
• Mechanism hypotheses for the electrophysiological manifestations of two cases of endplate acetylcholinesterase deficiency related congenital myasthenic syndrome.

  2018cites this paper
• Protein-anchoring therapy to target extracellular matrix proteins to their physiological destinations.

  2018cites this paper
• The triple helix of collagens – an ancient protein structure that enabled animal multicellularity and tissue evolution

  2018cites this paper
• Congenital Myasthenic Syndromes in 2018

  2018cites this paper
• Myasthenic syndromes due to defects in COL13A1 and in the N‐linked glycosylation pathway

  2018cites this paper
• From Structure to Phenotype: Impact of Collagen Alterations on Human Health

  2018cites this paper
• Animal Models of the Neuromuscular Junction, Vitally Informative for Understanding Function and the Molecular Mechanisms of Congenital Myasthenic Syndromes

  2018cites this paper
• The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes

  2018cites this paper
• A presynaptic congenital myasthenic syndrome attributed to a homozygous sequence variant in LAMA5

  2018cites this paper
• Autoimmune antibodies to collagen XIII in myasthenia gravis patients

  2018cites this paper
• Collagen XIII Is Required for Neuromuscular Synapse Regeneration and Functional Recovery after Peripheral Nerve Injury

  2018cites this paper
• Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease

  2017cites this paper
• The Increasing Genetic and Phenotypical Diversity of Congenital Myasthenic Syndromes

  2017cites this paper
• muscular dystrophies Gene Editing With CRISPR / Cas 9 RNA-Directed Nuclease

  2017cites this paper
• Collagen XIII secures pre- and postsynaptic integrity of the neuromuscular synapse

  2017cites this paper
• [Current status of congenital myasthenic syndromes].

  2017cites this paper
• New era in genetics of early-onset muscle disease: Breakthroughs and challenges.

  2017influential citation
• Region- and Cell-Specific Expression of Transmembrane Collagens in Mouse Brain

  2017cites this paper
• Congenital myasthenic syndromes: recent advances.

  2016cites this paper
• Clinical and genetic basis of congenital myasthenic syndromes Bases clínicas e genéticas das síndromes miastênicas congênitas

  2016cites this paper
• Clinical and genetic basis of congenital myasthenic syndromes.

  2016cites this paper
• Recent advances in congenital myasthenic syndromes

  2016influential citation
• Limb-girdle congenital myasthenic syndrome in a Chinese family with novel mutations in MUSK gene and literature review.

  2016cites this paper
• Congenital myasthenic syndromes.

  1997cites this paper